This week, the FDA approved Sanofi’s SNY hemophilia therapy, fitusiran, Novartis’ NVS Vanrafia for the reduction of ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Johnson & Johnson has signaled that it will attempt to disqualify certain plaintiffs' lawyers and use other aggressive ...

The EV maker is slated to report first-quarter sales data Wednesday morning. Wall Street expects just under 380,000 vehicles. The number reported probably won't be that high.

A federal bankruptcy judge has rejected Johnson & Johnson’s latest attempt to settle lawsuits that allege its talc baby ...

J&J and its subsidiary, Red River Talc, had proposed a $9 billion bankruptcy package to settle cancer claims linked to its ...

RBC Capital keeps an Outperform rating and $181 price target on Johnson & Johnson after U.S. Bankruptcy Court denied the company’s request ...

Now that the JNJ stock has seen a 7% fall, does the current price point make it attractive? Going by what you pay per dollar ...

Citi says Johnson & Johnson’s talc litigation “hit another snag,” with the judge in the bankruptcy case denying management’s proposed ...

A Johnson & Johnson unit’s latest dismissal from the bankruptcy court system shows how complex voting issues and overly broad ...

Bankruptcy judge rejects the healthcare-products company’s third attempt to resolve mass talc lawsuits through chapter 11.

A U.S. bankruptcy judge has denied Johnson & Johnson's settlement plan relating to its baby powder products containing talc.